A. Sanchez

发表

Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

A. Prussia, J. Murray, Jinsong Sheng, 2012, AIDS research and human retroviruses.

Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus

J. Lippincott-Schwartz, J. Murray, Jinsong Sheng, 2005, Journal of Virology.

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Christian Drosten, Larry J. Anderson, Brian Holloway, 2003, Science.

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.

Mike Bray, Angela M Gronenborn, Barry R O'Keefe, 2003, Antiviral research.

A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals.

B. Murphy, J. Ward, A. Sanchez, 2008, Virology.

Ebola Virus Selectively Inhibits Responses to Interferons, but Not to Interleukin-1β, in Endothelial Cells

A. Sanchez, B. Harcourt, M. Offermann, 1999, Journal of Virology.

Immunization for Ebola virus infection

E. Nabel, A. Sanchez, G. Nabel, 1998, Nature Medicine.

Transmission of COVID-19 From an Asymptomatic Mother to Fetus Leading to Death of Neonate From Pneumonia

A. Sanchez, Maryellen Campbell, Sai Palati, 2022, Cureus.

Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda.

A. Sanchez, P. Rollin, 2005, Virus research.

Successful Topical Respiratory Tract Immunization of Primates against Ebola Virus

B. Murphy, A. Sanchez, P. Rollin, 2007, Journal of Virology.

Successful Topical Respiratory Tract Immunization of Primates

B. Murphy, A. Sanchez, P. Rollin, 2007 .

Levels Responses , Virus Load , and Nitric Oxide Ebola ( Sudan ) Hemorrhagic Fever : Cellular Samples from Fatal and Nonfatal Cases of Analysis of Human Peripheral Blood

A. Sanchez, P. Rollin, D. Bausch, 2004 .

for Ebola virus infection in primates

A. Sanchez, N. Sullivan, G. Nabel, 2000 .

Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP.

A. Sanchez, P. Rollin, L. Barrientos, 2004, Biochemical and biophysical research communications.

Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome

Stuart T. Nichol, A. Sanchez, F. Kaducu, 2004, Journal of Virology.

Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus.

A. Sanchez, P. Rollin, D. Bausch, 2007, The Journal of infectious diseases.

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

E. Nabel, A. Sanchez, N. Sullivan, 2000, Nature Medicine.

Yang, Z.-Y. et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886-889

E. Nabel, A. Sanchez, N. Sullivan, 2000 .

Assessment of the risk of Ebola virus transmission from bodily fluids and fomites.

S. Dowell, A. Sanchez, F. Kaducu, 2007, The Journal of infectious diseases.

Endothelial Cells , in β to Interferons, but Not to Interleukin-1 Ebola Virus Selectively Inhibits Responses

A. Sanchez, B. Harcourt, 2013 .

Covalent Modifications of the Ebola Virus Glycoprotein

A. Sanchez, D. A. Sanders, S. Jeffers, 2002, Journal of Virology.

Mutational Analysis of the Putative Fusion Domain of Ebola Virus Glycoprotein

A. Sanchez, Shinji Watanabe, Y. Kawaoka, 1999, Journal of Virology.

Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.

Irah L. King, A. Sanchez, M. Tabrizian, 2015, Journal of Clinical Investigation.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

J. A. Comer, T. Greenough, A. Sanchez, 2005, Journal of Virological Methods.

Sequence-Based Human Leukocyte Antigen—B Typing of Patients Infected with Ebola Virus in Uganda in 2000: Identification of Alleles Associated with Fatal and Nonfatal Disease Outcomes

A. Sanchez, P. Rollin, K. Wagoner, 2007, Journal of Infectious Diseases.

Development of a preventive vaccine for Ebola virus infection in primates

A. Sanchez, N. Sullivan, G. Nabel, 2000, Nature.

Filoviridae: Marburg and ebola viruses

Heinz Feldmann, A. Sanchez, H. Feldmann, 2013 .

Variation in the Glycoprotein and VP35 Genes of Marburg Virus Strains☆

A. Sanchez, H. Feldmann, S. Nichol, 1998, Virology.

A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus Challenge

B. Murphy, A. Sanchez, P. Rollin, 2006, Journal of Virology.

Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels

Daniel Bausch, A. Sanchez, Daniel Bausch, 2004, Journal of Virology.

Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection

D. Burton, P. Parren, A. Sanchez, 1999, Journal of Virology.

Infection by Antibody Produced in Natural Human Ebola Virus Can Be Effectively Neutralized

D. Burton, P. Parren, A. Sanchez, 1999 .

Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus

A. Sanchez, G. Nabel, C. Peters, 1998, Journal of Virology.

Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity.

Angela M Gronenborn, Rafael Delgado, A. Gronenborn, 2004, Structure.

In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins.

Rafael Delgado, A. Sanchez, R. Delgado, 2004, The Journal of infectious diseases.

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

B. Strahl, A. Sanchez, R. Prinjha, 2022, The Journal of clinical investigation.

Ebola Zaire DNA vaccine in comparison to its use in combination with DNA from

A. Sanchez, N. Sullivan, G. Nabel, 2022 .

THE JOURNAL OF INFECTIOUS DISEASES

Scott, Yves, A. Sanchez, 2022 .

Annexin 1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection

Irah L. King, A. Sanchez, M. Tabrizian, 2017 .

Filoviruses as emerging pathogens

A. Sanchez, H. Feldmann, T. Ksiazek, 1994 .

Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity.

A. Sanchez, 2007, The Journal of infectious diseases.

Ebola Virus Glycoprotein 1: Identification of Residues Important for Binding and Postbinding Events

A. Sanchez, D. A. Sanders, P. McCray, 2007, Journal of Virology.

Molecular biology and evolution of filoviruses.

A. Sanchez, H. Feldmann, H. Klenk, 1993, Archives of virology. Supplementum.

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness.

J. Childs, A. Sanchez, H. Feldmann, 1993, Science.

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

A. Sanchez, G. Rodier, D. Heymann, 1999, The Journal of infectious diseases.

Genome structure and variability of a virus causing hantavirus pulmonary syndrome.

A. Sanchez, H. Feldmann, C. Peters, 1994, Virology.

Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells.

A. Sanchez, B. Harcourt, M. Offermann, 1998, Virology.

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.

A. Sanchez, G. Nabel, Ling Xu, 1998, Science.

A system for functional analysis of Ebola virus glycoprotein.

A. Sanchez, H. Goto, Y. Kawaoka, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

A. Sanchez, A. Rowe, T. Ksiazek, 1999, The Journal of infectious diseases.

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

A. Sanchez, C. Peters, B. Mahy, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States.

A. Sanchez, P. Jahrling, T. Ksiazek, 1999, The Journal of infectious diseases.

Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates.

A. Sanchez, Ali S Khan, T. Ksiazek, 1999, The Journal of infectious diseases.

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.

A. Sanchez, P. Jahrling, M. Bray, 2000, Vaccine.

Recombinant human monoclonal antibodies to Ebola virus.

D R Burton, D. Burton, P. Parren, 1999, The Journal of infectious diseases.

Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.

S. R. Zaki, A. Sanchez, M. Georges-Courbot, 1997, Emerging infectious diseases.

Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.

A. Sanchez, Ali S Khan, T. Ksiazek, 1999, The Journal of infectious diseases.

Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle.

A. Sanchez, H. Feldmann, H. Klenk, 1992, Virus research.

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus.

A. Sanchez, A. Sanchez, A Sanchez, 1993, Virus research.

Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses.

A. Sanchez, H. Feldmann, H. Klenk, 1992, The Journal of general virology.

Identification of a new North American hantavirus that causes acute pulmonary insufficiency.

A. Sanchez, H. Feldmann, Ali S Khan, 1995, The American journal of tropical medicine and hygiene.

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein.

A. Sanchez, H. Feldmann, H. Klenk, 1994, Virology.